Prof Ghosh has served several years in leadership role in Research & Development, Academics, Technology Management as well as in Scientific Administration in leading Institutions in the country and abroad Prof. Ghosh with is vast techno-commercial knowledge in the domain has Co-foundedVaxfarm Life Sciences a specialised vaccine R&D Company to promote a fast track product development. Dr. Ghosh has a wide cross functional experience in Government, Public Sector Enterprise and in the corporate world. He has been in the field Research, Innovation & Technology Management function for over past 30 years and was instrumental in the commercialization of a number of early stage innovations and technologies. In his leadership role in R&D he has lead the development of number of Vaccines in real time basis including the India’s first Dengue Vaccine and the advance Pneumococcal Conjugate Vaccine currently under clinical development. Dr. Ghosh has a Post Graduate degree in Bio-Engineering from Indian Institute of Technology, Kharagpur and his Doctoral degree from Indian Institute of Technology, New Delhi. As a prestigious World Bank Scholar he has also carried out his research at leading European University. He is a member of the national committees of the apex bodies. He is also the Member of the Executive Board of the Asian Federation of Biotechnology based at Seoul. South Korea.
Anurag has a versatile industrial experience over 18 years in Pharmaceutical, Biotech & Vaccine Research and Manufacturing at leading pharmaceutical
companies in India such as Torrent Research Centre, Ranbaxy laboratories ltd, and Panacea Biotec Ltd. Anurag has worked as Viral Vaccine Process
Development Scientist at Panacea Biotec Ltd. and engaged in developing a number of Vaccines and Biological on a real-time basis such as H1N1, Seasonal Flu Vaccine,
Measles Rubella and Varicella Vaccine including the India’s first Dengue Vaccine which is currently in clinical development.He was also responsible for successfully
bridging the process between R&D and the manufacturing set up in a GMP environment. With his vast experience in cell culture domain coupled with his problem solving skills and resiliency, he leads his project team that carries through the scale-up development phase for faster product delivery.
A Clinician by profession and the Co-founder of Vaxfarm Life Sciences, a Medical Graduate and have a strong acumen to conduct and participate in areas of medical research. He has been helping the company with the responsibility for the ethical conduct of research for the safe performance of clinical studies and for evaluating the new drug efficacy of a new potential treatments. He plays an active role in promoting an open and critical discussion while sharing industrial views and opinions with colleagues from academia as a constructive cooperation between both worlds, avoiding a black-and-white view, will we achieve an instrumental and effective way in developing new and affordable solutions.
Nabamit is a physician trained in general medicine, clinical development, biosafety and ethical issues. Prior to joining Vaxfarm he actively dealt with large number of Covid-19 patients at specialised Covid hospital. He works closely with the medical information and the clinical research team that provides significant contribution towards the evaluation, assessment and communication of important medical / scientific information related to a company’s products under development. He also helps in biosafety training and practices in the company.
An Academician, Scientist and Industrialist, PhD from PGIMER, Chandigarh with 42 years of academic and industrial research experience. Engaged in medical research at University of Pennsylvania, Northwestern University, Georgetown University, and Walter Reed Army Institute of Research in USA. Expertise in Life Sciences & Biotechnology. Pioneered Nano-Drug R&D, Innovation and Translational Research. First in Indian Industry for application of Liposome Technology for drugs, diagnostics and vaccines. Developed and Commercialized India’s first Liposomal product and world’s only Liposomal diagnostic - Liposome agglutination test for Syphilis. Contributed to Asia’s first and world’s best antifungal drug FUNGISOME - a Liposomal Amphotericin B. which earned him many distinctions and awards including DBT’s National Biotechnology award, National Technology Day award and others. Dr.Verma Keenly involved in translational research for taking benefits of Science & Technology by applications in everyday life.
Dr Chattopadhyay, currently teaches at Aston University, UK specializes in combining techniques from Stochastic Mathematics, Statistical Physics, Machine Learning and Artificial Intelligence, to solve application-oriented problems in biology, nanomaterial and bioinformatics and new drug design. He specializes in mathematical modelling of complex systems combining conventional Machine Learning with statistical mechanics tool boxes. He has made ground-breaking contributions in mapping proteomic and genomic sequences against their functional groups towards drug repurposing; enumerating the influence of lifestyle health factors in cardiovascular diseases. Dr Chattopadhyayis a Fellow of Alexander von Humboldt Foundation and also the first Indian Scientist to become Marie Curie Fellow in physics. Dr Chattopadhyay excels in interdisciplinary research with a substantial history of success cross-disciplinary science.
© 2020 Vaxfarm.com. All Rights Reserved | Design by Notional Infosoft